New clinical trial
Pattern of Gait and Assessment Regarding Pathophysiology and Mechanism and Its Relation to Cognition, VEP, and Radiology as Prediction of Progression of Disease in Multiple Sclerosis Patients
@gregoryai.bsky.social
@gregoryai.bsky.socialNew clinical trial
Pattern of Gait and Assessment Regarding Pathophysiology and Mechanism and Its Relation to Cognition, VEP, and Radiology as Prediction of Progression of Disease in Multiple Sclerosis Patients
@gregoryai.bsky.socialNew clinical trial
Frequency and Clinical Significance of Epstein-Barr Virus Antibody Titers in Egyptian Patients With Multiple Sclerosis
@gregoryai.bsky.socialNew clinical trial
Effects of Inductive Therapeutic Exercise on Muscle Tone, Postural Control, and Quality of Life in Patients With Multiple Sclerosis.
@alliance-org.bsky.socialDiscover the latest advances in breast, lung & prostate cancer care! Join the Alliance for a free public webinar on Oct 1 featuring leading researchers & patient advocates sharing key findings from #ASCO26. Register now: bit.ly/Alliance-Webinar-Oct26 #clinicaltrials
@tickerade.bsky.social💰 Viking Therapeutics $VKTX raised ~$575M through a stock and convertible-note offering, fueling increased takeover speculation despite the stock falling 5.7% from its $35 offering price.
#clinicaltrials
@conciercare.bsky.socialMilvexian changed blood-clotting biology—but didn’t improve outcomes after acute coronary syndrome. A powerful reminder that successful mechanisms don’t always translate into clinical benefit.
#Cardiology #ClinicalTrials #HeartHealth #Telehealth #MedicalResearch
@gregoryai.bsky.socialNew clinical trial
Choose Myself (Before) Losing Myself: Providing Educational Information to Empower Alzheimer's Dementia Patients and Their Caregivers Utilizing Gamification Techniques Such as Choose Your Own Adventure.
@gregoryai.bsky.socialNew clinical trial
Neuroprotective Effects of Oleanolic Acid and Erythrodiol in Prodromal Alzheimer's Disease
@eara.eu#GeneTherapy silences #HepatitisB virus in #mice 🧬
A #therapy developed in Italy (San Raffaele Telethon Institute for Gene Therapy) and the US (nChroma Bio) reduced #HBV activity in #mice and proved safe in #monkeys, paving the way for #ClinicalTrials.
Learn more: 🔗 www.eara.eu/news/gene-th...
@aktiego.bsky.socialTwo very different kinds of biotech news this week: one Phase 2 trial hit its end point and the stock still couldn't hold the gain, the other missed its endpoint outright in a pediatric rare disease.
The Trial Results Explained at → aktiego.com
NFA. DYOR.
@biorasi.bsky.socialDon't guess. Choose your first step with #BiorasiHive.
@Biorasi Hive optimizes drug development right from the start by pressure testing scenarios that match your study design, eligibility, and more >> youtu.be/BK2XchEGGSU
@gregoryai.bsky.socialNew clinical trial
Disease Modifying Therapy Use in Women With Multiple Sclerosis Before, During, and After Pregnancy
@gregoryai.bsky.socialNew clinical trial
A study to investigate safety and effectiveness of REM0045392 compared with placebo in healthy elderly participants and participants with Alzheimer’s disease
@biotechstockdaily.bsky.socialOruka reports deeper Week 28 psoriasis responses for
ORKA-001 following two induction doses. The results come from a small Phase 2a trial.
#Biotech #BiotechStocks #ClinicalTrials #Phase2
Disclaimer: This is NOT a financial advice
@themednet.bsky.socialThe Plenary Session at the American Society for Radiation Oncology (ASTRO) Annual Meeting 2026 has ended.
Experts are now answering questions on Mednet.
Head to the Q&A → gqr.sh/QpfP
@gregoryai.bsky.socialNew clinical trial
Prevalence, Clinical Characteristics, and Management of Neurocutaneous Syndromes in Children
@gregoryai.bsky.socialNew clinical trial
A Placebo-Controlled, Single- and Multiple-Ascending Dose, Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4560736 in Healthy Participants and Participants With Alzheimer's Di...
@liposarcomasupport.bsky.socialA new clinical trial is exploring SA53-OS, an MDM2 inhibitor, for people with advanced solid tumors, including #dedifferentiated #liposarcoma (#DDLPS). Learn more about this study, who may be eligible, and how the treatment is given.
clinicaltrials.gov/study/NCT065...
#ClinicalTrials #MDM2
@fightcrc.bsky.socialOur #ClinicalTrials newsletter delivers the latest trial highlights, global research updates, and insights from advocates and experts straight to your inbox.
Stay informed, empowered, and ready for what's next. Subscribe today: fightcrc.org/subscribe
@ajnamdeplume.bsky.social